CompletedNot Applicable

Arterial Stiffness, Blood Pressure and Cardiac Output Study

Netherlands20 participantsStarted 2017-04-24

Plain-language summary

Comparison of non-invasively obtained central blood pressure using SphygmoCor and invasively recorded central blood pressure in patients with an AAA that will be treated with EVAR.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or female at least 18 years old;
✓. Informed consent form understood and signed and patient agrees to follow-up visits;
✓. Have a infrarenal abdominal aortic aneurysm (AAA) with maximum sac diameter ≥ 5.5cm, or an AAA ≥ 4.5 cm which has increased by \> 1.0 cm in the past year with a scheduled endovascular intervention

Exclusion criteria

✕. Life expectancy \< 2 years;
✕. Psychiatric or other condition that may interfere with the study;
✕. Participating in another clinical study, interfering on outcomes;
✕. Irregular pulse;
✕. Presence of extensive peripheral arterial disease (ABI \< 0.9 or obstruction validated on imaging); dated less than 3 months prior to treatment
✕. Ruptured, leaking or mycotic aneurysm;

What they're measuring

central blood pressure

Timeframe: one week

Trial details

NCT IDNCT03469388

SponsorRijnstate Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-05

View on ClinicalTrials.gov More Infrarenal Abdominal Aortic Aneurysm trials